NGNE vs SPY
Neurogene Inc (NGNE) versus SPDR S&P 500 ETF Trust (SPY) — a side-by-side from cached financials, not a winner call.
Neurogene Inc (NGNE) is a biotechnology company listed on US.
SPDR S&P 500 ETF Trust (SPY) common stock listed on US.
Latest reported NGNE revenue for 2025-09-30 was $0. Net income was -$21.0M. NGNE currently screens at market cap $286.5M.
SPY does not have a complete income-statement cache yet.
NGNE currently screens at market cap $286.5M. SPY currently screens at market cap $0.
Not investment advice. Open the NGNE and SPY stock pages for the full models.
Not investment advice.